Code Name | Mitochondria-targeting moieties (M) | Therapeutic agents (T) | Diagnostic/Imaging agents (D) | Therapeutic effects | Diagnostic/Imaging modes | Remarks | References |
---|---|---|---|---|---|---|---|
Drug-loadable TPP-C NPs | TPP | Doxorubicin (model drug) | coumarin | Antitumor activity | Fluorescence imaging | Self-assembled NPs of chemical conjugates | [36] |
PEG-(PhA)2 (PPA) NPs | Pheophorbide a (PhA) | PhA | PhA | ROS-mediated tumor cell killing | Fluorescence Imaging | M-T-D 3-in-1 typed NPs, Self-assembled NPs of chemical conjugates | [37] |
PPAn-TPCL4-n mixed NPs of PEG-(PhA)2 (PPA) and TPP-b-PCL-b-TPP (TPCL) | PhA, TPP | PhA | PhA | ROS-mediated tumor cell killing | Fluorescence Imaging | M-T-D 3-in-1 typed NPs, Self-assembled NPs of chemical conjugates, Dual M type | [37] |
TICT | TPP | IR780, Ce6 | IR780, Ce6 | Photodynamic therapy (PDT) & Photothermal therapy (PTT) | Near-infrared (NIR) fluorescence imaging, photoacoustic imaging | T-D 2-in-1 typed NPs | [38] |
IR-780-PEG-b-polyMTOS NPs | A methacrylic derivative of α-tocopheryl succinate (MTOS) | MTOS, IR-780 | IR-780 | MTOS-mediated apoptosis, IR-780-mediated PDT & PTT | NIR fluorescence imaging | M-T 2-in-1 & T-D 2-in-1 typed NPs | [39] |
TAT-Ppa-UNCPs | TAT peptide (YGRKKRRQRRR) | Pyropheophorbide a (Ppa) | Ppa | ROS-mediated tumor cell killing | NIRÂ fluorescence imaging | T-D 2-in-1 typed NPs | [40] |
CDs-RB | Carbon dots (CD) composed of chitosan, ethylenediamine, and mercaptosuccinic acid | Rose Bengal (RB) | CD | ROS-mediated tumor cell killing | Fluorescence Imaging | M-D 2-in-1 typed NPs | [41] |
Cdot-TPP-SNO | TPP | Cdot | Nitric oxide (NO) | NO-induced apoptosis | Fluorescence Imaging | NPs | [42] |
ICG-loaded MMCNs | TPP | Indocyanine green (ICG) | ICG, Fe3O4 | ICG-mediated PDT & PTT | NIR fluorescence imaging, Magnetic resonance (MR) imaging | Bimodal imaging NPs | [43] |
C3N4-Fe-TPP NF/MB | TPP | Methylene blue (MB) | FeIII, MB | PDT | Fluorescence imaging, MR imaging | NSs | [44] |